2001
DOI: 10.1176/appi.psy.42.6.461
|View full text |Cite
|
Sign up to set email alerts
|

Corticosteroid-Induced Psychotic and Mood Disorders: Diagnosis Defined by DSM-IV and Clinical Pictures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
87
0
14

Year Published

2002
2002
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 120 publications
(102 citation statements)
references
References 19 publications
1
87
0
14
Order By: Relevance
“…Testosterone levels are also inversely correlated to the incidence of negative symptoms in schizophrenia and to the poverty of clinical outcome (Akhondzadeh et al, 2006;Goyal et al, 2004). The participation of other NSs, such as glucocorticoids, in the effects of 5AR inhibitors cannot be completely ruled out, in view of their major role in stress and psychosis (Wada et al, 2001). This possibility, however, is partially challenged by preliminary clinical observations, reporting that FIN does not significantly alter circulating cortisol levels (Rittmaster et al, 1994;Uygur et al, 1998).…”
Section: -A-reductase Inhibitors In Models Of Psychosis M Bortolato mentioning
confidence: 99%
“…Testosterone levels are also inversely correlated to the incidence of negative symptoms in schizophrenia and to the poverty of clinical outcome (Akhondzadeh et al, 2006;Goyal et al, 2004). The participation of other NSs, such as glucocorticoids, in the effects of 5AR inhibitors cannot be completely ruled out, in view of their major role in stress and psychosis (Wada et al, 2001). This possibility, however, is partially challenged by preliminary clinical observations, reporting that FIN does not significantly alter circulating cortisol levels (Rittmaster et al, 1994;Uygur et al, 1998).…”
Section: -A-reductase Inhibitors In Models Of Psychosis M Bortolato mentioning
confidence: 99%
“…The pathophysiological mechanisms giving rise to the psychiatric symptoms associated with corticosteroid treatment remain unclear. Many probable mechanisms have been proposed like corticosteroid effects on dopaminergic and cholinergic systems, decreases in serotonin release, and toxic effects on hippocampal neurons or on other brain regions [13][14][15]. Clinical Psychiatry neuroimaging finding were consistent with Sheehan's syndrome.…”
Section: Discussionmentioning
confidence: 98%
“…If the daily dose of corticosteroid is below 40 mg, the risk is considered to be low; if the dose is between 40 and 80 mg, the risk is considered to be moderate; and if the dose is more than 80 mg, the risk is considered to be high (6). Regardless of the dose, the rate of psychiatric side effects for cortisol is reported to be 5.7% (7). However, neither the dose nor other distinguishing factors can determine the severity of the psychiatric disorder in advance.…”
Section: Discussionmentioning
confidence: 99%